The future of clinical research depends on people just as much as strong systems and processes. Learn what makes great ...

There is a great need to develop, standardize, assess, and validate clinical protocols and standard operating procedures for vascularized composite allotransplantation transplants, with the goal of ...

The U.S. Food and Drug Administration (FDA) published the draft guidance “Protocol Deviations for Clinical Investigations of Drugs, Biological Products, and Devices,” which provides advice for ...

Please provide your email address to receive an email when new articles are posted on . ASN’s framework focuses on how AI can benefit patients by using clinical datasets. Data quality, bias and ...

Developing a new life-saving drug or medical device is fraught with challenges. But while challenges often vary from program to program, one in particular is guaranteed: uncertainty. In this article, ...

As the curtain closed on 2024, FDA issued a new draft guidance to assist clinical trial sponsors, investigators, and institutional review boards (“IRBs”) with defining, identifying, and reporting ...

The engagement establishes a multi-phase framework to support AI enabled capital efficient development of Teverelix, a next generation GnRH antagonist, as a first in class market product for acute ...

A committee-supported project or activity that has been completed and for which output dissemination has begun. Its committee has been disbanded and closeout procedures are underway. Articulate ...